Imported biologicals: unforeseen biosecurity risks in the laboratory
Annette M Dougall A B , Tim R Brinkley A C and Brian D Clarke A D
+ Author Affiliations
- Author Affiliations
A Biosecurity Animal Division, Australian Government Department of Agriculture, Water and the Environment, Canberra, ACT, Australia
B Email: annette.dougall@awe.gov.au
C Email: tim.brinkley@awe.gov.au
D Email: brian.clarke@awe.gov.au
Microbiology Australia 41(3) 132-135 https://doi.org/10.1071/MA20035
Published: 13 August 2020
Abstract
Imported biological products are ubiquitous necessities of modern life that can pose significant biosecurity risks to Australia. Products produced using animal material are used everywhere from enzymes in cleaning products, to cell lines and bacterial cultures used to produce vaccines and medicines. This article highlights adventitious agents of biologicals and provides an overview of the considerations and regulatory tools administered under the Biosecurity Act 2015 (Commonwealth) to manage these biosecurity risks whilst still facilitating imports of biologicals.
References
[1] Department of Health (2020) Security Sensitive Biological Agents. https://www1.health.gov.au/internet/main/publishing.nsf/Content/ssba.htm (updated 4 March 2020).[2] Department of Agriculture (2019) National notifiable disease list of terrestrial animals. Canberra: Department of Agriculture, Water and the Environment. https://www.agriculture.gov.au/sites/default/files/documents/notifiable.pdf (updated April 2019).
[3] Australian Bureau of Agricultural and Resource Economics and Sciences (2019) Interim priority list of exotic environmental pests and diseases Canberra: Department of Agriculture, Water and the Environment. https://www.agriculture.gov.au/biosecurity/environmental/priority-list (updated 4 February 2020).
[4] Department of Agriculture (2019) Appropriate Level of Protection. Canberra: Department of Agriculture, Water and the Environment. https://www.agriculture.gov.au/biosecurity/risk-analysis/conducting/appropriate-level-of-protection (updated 4 November 2019).
[5] Wurtz, N. et al. (2016) Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories. Eur. J. Clin. Microbiol. Infect. Dis. 35, 1247–1258.
| Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories.Crossref | GoogleScholarGoogle Scholar | 27234593PubMed |
[6] Klug, B. et al. (2016) Adventitious agents and live viral vectored vaccines: considerations for archiving samples of biological materials for retrospective analysis. Vaccine 34, 6617–6625.
| Adventitious agents and live viral vectored vaccines: considerations for archiving samples of biological materials for retrospective analysis.Crossref | GoogleScholarGoogle Scholar | 27317264PubMed |
[7] World Health Organization. Annex 3 Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks. WHO Expert Committee on Biological Standardization, sixty-first report. WHO technical report series; no. 9782013.
[8] Garner, M.G. et al. (2002) Economic aspects of foot and mouth disease: perspectives of a free country, Australia. Rev. Sci. Tech. 21, 625–635.
| Economic aspects of foot and mouth disease: perspectives of a free country, Australia.Crossref | GoogleScholarGoogle Scholar | 12523702PubMed |
[9] Drexler, H.G. et al. (2002) Mix-ups and mycoplasma: the enemies within. Leuk. Res. 26, 329–333.
| Mix-ups and mycoplasma: the enemies within.Crossref | GoogleScholarGoogle Scholar | 11839374PubMed |
[10] Volokhov, D.V. et al. (2008) Biological enrichment of mycoplasma agents by cocultivation with permissive cell cultures. Appl. Environ. Microbiol. 74, 5383–5391.
| Biological enrichment of mycoplasma agents by cocultivation with permissive cell cultures.Crossref | GoogleScholarGoogle Scholar | 18606798PubMed |
[11] Bairoch, A. (2018) The Cellosaurus, a cell-line knowledge resource. J. Biomol. Tech. 29, 25–38.
| The Cellosaurus, a cell-line knowledge resource.Crossref | GoogleScholarGoogle Scholar | 29805321PubMed |
[12] Capes-Davis, A. et al. (2010) Check your cultures! A list of cross-contaminated or misidentified cell lines. Int. J. Cancer 127, 1–8.
| Check your cultures! A list of cross-contaminated or misidentified cell lines.Crossref | GoogleScholarGoogle Scholar | 20143388PubMed |
[13] Horbach, S.P.J.M. and Halffman, W. (2017) The ghosts of HeLa: how cell line misidentification contaminates the scientific literature. PLoS One 12, e0186281.
| The ghosts of HeLa: how cell line misidentification contaminates the scientific literature.Crossref | GoogleScholarGoogle Scholar |
[14] Uryvaev, L.V. et al. (2012) Contamination of cell cultures with bovine viral diarrhea virus (BVDV). Bull. Exp. Biol. Med. 153, 77–81.
| Contamination of cell cultures with bovine viral diarrhea virus (BVDV).Crossref | GoogleScholarGoogle Scholar | 22808499PubMed |
[15] Eschbaumer, M. et al. (2011) Contamination in bluetongue virus challenge experiments. Vaccine 29, 4299–4301.
| Contamination in bluetongue virus challenge experiments.Crossref | GoogleScholarGoogle Scholar | 21557978PubMed |
[16] Dulac, G.C. and Afshar, A. (1989) Porcine circovirus antigens in PK-15 cell line (ATCC CCL-33) and evidence of antibodies to circovirus in Canadian pigs. Can. J. Vet. Res. 53, 431–433.
| 2686830PubMed |
[17] Bolin, S.R. et al. (1994) Detection of a cell line contaminated with hog cholera virus. J. Am. Vet. Med. Assoc. 205, 742–745.
| 7989247PubMed |
[18] Leslie, E. et al. (2014) Effective surveillance strategies following a potential classical swine fever incursion in a remote wild pig population in North-Western Australia. Transbound. Emerg. Dis. 61, 432–442.
| Effective surveillance strategies following a potential classical swine fever incursion in a remote wild pig population in North-Western Australia.Crossref | GoogleScholarGoogle Scholar | 23294519PubMed |
[19] Garner, M.G. et al. (2001) The expected economic impact of selected exotic diseases on the pig industry of Australia. Rev. Sci. Tech. 20, 671–685.
| The expected economic impact of selected exotic diseases on the pig industry of Australia.Crossref | GoogleScholarGoogle Scholar | 11732410PubMed |
[20] House, J.A. et al. (1988) Characteristics of the porcine kidney cell line IB-RS-2 clone D10 (IB-RS-2 D10) which is free of hog cholera virus. In Vitro Cell. Dev. Biol. 24, 677–682.
| Characteristics of the porcine kidney cell line IB-RS-2 clone D10 (IB-RS-2 D10) which is free of hog cholera virus.Crossref | GoogleScholarGoogle Scholar | 2840431PubMed |
[21] Shimizu, Y. et al. (1969) Porcine kidney cell line persistently contaminated with avirulent swine fever virus. J. Gen. Virol. 4, 625–628.
| Porcine kidney cell line persistently contaminated with avirulent swine fever virus.Crossref | GoogleScholarGoogle Scholar | 5816816PubMed |
[22] Ma, H. et al. (2011) Investigations of porcine circovirus type 1 (PCV1) in vaccine-related and other cell lines. Vaccine 29, 8429–8437.
| Investigations of porcine circovirus type 1 (PCV1) in vaccine-related and other cell lines.Crossref | GoogleScholarGoogle Scholar | 21835219PubMed |
[23] Bolin, S.R. et al. (1991) Methods for detection and frequency of contamination of fetal calf serum with bovine viral diarrhea virus and antibodies against bovine viral diarrhea virus. J. Vet. Diagn. Invest. 3, 199–203.
| Methods for detection and frequency of contamination of fetal calf serum with bovine viral diarrhea virus and antibodies against bovine viral diarrhea virus.Crossref | GoogleScholarGoogle Scholar | 1655059PubMed |
[24] Bolin, S.R. and Ridpath, J.F. (1998) Prevalence of bovine viral diarrhea virus genotypes and antibody against those viral genotypes in fetal bovine serum. J. Vet. Diagn. Invest. 10, 135–139.
| Prevalence of bovine viral diarrhea virus genotypes and antibody against those viral genotypes in fetal bovine serum.Crossref | GoogleScholarGoogle Scholar | 9576339PubMed |
[25] Pinheiro de Oliveira, T.F. et al. (2013) Detection of contaminants in cell cultures, sera and trypsin. Biologicals 41, 407–414.
| Detection of contaminants in cell cultures, sera and trypsin.Crossref | GoogleScholarGoogle Scholar | 24071554PubMed |
[26] Bolin, S.R. et al. (1994) Survey of cell lines in the American Type Culture Collection for bovine viral diarrhea virus. J. Virol. Methods 48, 211–221.
| Survey of cell lines in the American Type Culture Collection for bovine viral diarrhea virus.Crossref | GoogleScholarGoogle Scholar | 7989438PubMed |
[27] Palomares, R.A. et al. (2013) Bovine viral diarrhea virus fetal persistent infection after immunization with a contaminated modified-live virus vaccine. Theriogenology 79, 1184–1195.
| Bovine viral diarrhea virus fetal persistent infection after immunization with a contaminated modified-live virus vaccine.Crossref | GoogleScholarGoogle Scholar | 23561853PubMed |
[28] Fox, K.A. et al. (2019) Bovine viral diarrhea in captive Rocky Mountain bighorn sheep associated with administration of a contaminated modified-live bluetongue virus vaccine. J. Vet. Diagn. Invest. 31, 107–112.
| Bovine viral diarrhea in captive Rocky Mountain bighorn sheep associated with administration of a contaminated modified-live bluetongue virus vaccine.Crossref | GoogleScholarGoogle Scholar | 30541417PubMed |
